{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Schiller, Howard B", "name": "persons", "rank": "2", "is_major": "Y"}, {"value": "Pearson, John Michael (1959- )", "name": "persons", "rank": "3", "is_major": "Y"}, {"value": "Ingram, Robert A", "name": "persons", "rank": "4", "is_major": "Y"}, {"value": "Appointments and Executive Changes", "name": "subject", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/01/07/business/valeant-names-howard-b-schiller-interim-ceo.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/01/07/business/07valeant-web/07valeant-web-thumbWide.jpg", "legacy": {"wide": "images/2016/01/07/business/07valeant-web/07valeant-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/01/07/business/07valeant-web/07valeant-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/07/business/07valeant-web/07valeant-web-articleLarge.jpg", "xlargeheight": "953", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 953}, {"url": "images/2016/01/07/business/07valeant-web/07valeant-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/07/business/07valeant-web/07valeant-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "609", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Robert Ingram was also named interim chairman as J. Michael Pearson, the leader of the embattled company, remains hospitalized with severe pneumonia.", "pub_date": "2016-01-07T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant Names 2 Directors Interim Chief and Chairman", "main": "Valeant Names Howard B. Schiller Interim C.E.O."}, "print_page": "5", "snippet": "Robert Ingram was also named interim chairman as J. Michael Pearson, the leader of the embattled company, remains hospitalized with severe pneumonia.", "_id": "568d214a38f0d803f4a0c768", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals names Howard B Schiller as interim chief executive as its leader J Michael Pearson recovers from pneumonia; names Robert Ingram as interim chairman."}